米国企業
NEOGENOMICS INC

NEOGENOMICS INCNEO

時価総額

$17.8億

PER

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日
Cash and cash equivalents	3	2	5	34	23	13	13	10	173	229	317	263	342
Marketable securities, at fair value	-	-	-	-	-	-	-	-	-	-	-	175	73
Accounts receivable, net	8	14	19	20	49	56	60	77	94	107	112	120	131
Inventories	1	2	2	3	5	6	7	9	14	30	23	24	24
Prepaid assets	-	-	-	-	-	-	-	8	6	12	12	15	18
Assets held for sale	-	-	-	-	-	-	-	-	-	-	10	-	-
Other current assets	-	-	-	-	-	-	-	1	3	5	8	8	8
Other current assets	-	-	-	-	-	-	-	1	3	5	8	8	8
Total current assets	13	19	27	59	99	79	85	104	291	449	682	605	597
Total current assets	13	19	27	59	99	79	85	104	291	449	682	605	597
Property, Plant and Equipment, Net	7	9	10	15	35	34	37	61	64	86	109	102	92
Operating lease right-of-use assets	-	-	-	-	-	-	-	-	26	46	102	96	92
Intangible assets, net	-	3	3	-	-	-	-	140	127	121	442	408	373
Goodwill	-	-	-	3	146	147	147	198	199	211	527	523	523
Other assets	0	0	0	0	0	0	1	3	3	5	7	5	5
Total non-current assets	7	11	12	22	269	258	258	401	419	540	1,188	1,135	1,084
Total assets	20	30	40	81	368	337	343	505	710	988	1,870	1,740	1,681
Total assets	20	30	40	81	368	337	343	505	710	988	1,870	1,740	1,681
Accounts payable	3	4	4	6	12	17	10	18	20	25	18	21	20
Accrued compensation	2	3	2	4	6	8	9	19	21	25	38	40	53
Accrued expenses and other liabilities	-	-	-	-	7	4	6	9	8	12	18	15	15
Finance Lease, Liability, Current	-	-	-	-	-	-	-	-	-	3	1	0	-
Operating Lease, Liability, Current	-	-	-	-	-	-	-	-	-	5	7	7	6
Contract liabilities	-	-	-	-	-	-	-	1	2	4	5	8	2
Total current liabilities	11	18	14	15	40	38	35	61	64	73	87	90	96
Convertible Debt, Noncurrent	-	-	-	-	-	-	-	-	-	168	532	535	538
Operating lease liabilities	-	-	-	-	-	-	-	-	-	42	72	69	68
Deferred income tax liabilities, net	-	-	-	-	-	-	-	22	16	5	55	35	24
Other long-term liabilities	-	-	-	-	-	-	-	3	4	4	14	13	13
Total long-term liabilities	3	3	4	6	90	112	103	124	138	221	674	652	643
Total liabilities	14	21	18	21	130	151	138	185	202	294	762	742	740
Common Stock, Value, Outstanding	-	-	-	-	0	0	0	0	0	0	0	0	0
Additional paid-in capital	28	32	42	80	231	216	230	372	520	701	1,124	1,161	1,190
Accumulated other comprehensive loss	-	-	-	-	-	-	0	-1	-2	0	-1	-4	-2
Accumulated deficit	-23	-23	-21	-19	-22	-52	-57	-51	-11	-7	-15	-159	-247
Total stockholders’ equity	6	9	22	60	210	164	173	320	507	694	1,108	998	942
Total liabilities and stockholders’ equity	20	30	40	81	368	337	343	505	710	988	1,870	1,740	1,681
Accounts payable	3	4	4	6	12	17	10	18	20	25	18	21	20
Accrued compensation	2	3	2	4	6	8	9	19	21	25	38	40	53
Accrued expenses and other liabilities	-	-	-	-	7	4	6	9	8	12	18	15	15
Finance Lease, Liability, Current	-	-	-	-	-	-	-	-	-	3	1	0	-
Operating Lease, Liability, Current	-	-	-	-	-	-	-	-	-	5	7	7	6
Contract liabilities	-	-	-	-	-	-	-	1	2	4	5	8	2
Total current liabilities	11	18	14	15	40	38	35	61	64	73	87	90	96
Convertible Debt, Noncurrent	-	-	-	-	-	-	-	-	-	168	532	535	538
Operating lease liabilities	-	-	-	-	-	-	-	-	-	42	72	69	68
Deferred income tax liabilities, net	-	-	-	-	-	-	-	22	16	5	55	35	24
Other long-term liabilities	-	-	-	-	-	-	-	3	4	4	14	13	13
Total long-term liabilities	3	3	4	6	90	112	103	124	138	221	674	652	643
Total liabilities	14	21	18	21	130	151	138	185	202	294	762	742	740
Common Stock, Value, Outstanding	-	-	-	-	0	0	0	0	0	0	0	0	0
Additional paid-in capital	28	32	42	80	231	216	230	372	520	701	1,124	1,161	1,190
Accumulated other comprehensive loss	-	-	-	-	-	-	0	-1	-2	0	-1	-4	-2
Accumulated deficit	-23	-23	-21	-19	-22	-52	-57	-51	-11	-7	-15	-159	-247
Total stockholders’ equity	6	9	22	60	210	164	173	320	507	694	1,108	998	942
Total liabilities and stockholders’ equity	20	30	40	81	368	337	343	505	710	988	1,870	1,740	1,681